The research topic focus on ultrasound imaging and biomedical signal processing, especially in the cross-field integration of medicine, physics and engineering. Research directions include high-resolution ultrasound imaging/ultrasonic contrast agent development, ultrasound contrast agent nonlinear imaging/drug delivery and control release, ultrasound molecular imaging and blood-brain barrier opening, ultrasound code-excitating imaging-aided diagnosis technology, ultrasound-induced thrombolysis technique development and ultrasonic liquid lens probe development. The future research topics will be continue to deepen and broaden.

Prof. Chih-Kuang Yeh specializes in ultrasound biomolecular diagnosis, treatment, and drug delivery research. His research and innovation breakthrough lie in the development of ultrasound-responsible agents for ultrasound imaging and drug delivery: 

(1) ultrasonic imaging agent development (drug/gene carrier), including MBs, acoustic phase change droplets, and superhydrophobic acoustic-sensitive nanoparticles.

(2) establishment of ultrasound imaging system and the development of algorithms. 

(3) application and integration of experimental models from external cells and animals.